查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566898

體外膜氧合市場：按類型、成分、應用分類：2024-2033 年全球機會分析與產業預測

Extracorporeal Membrane Oxygenation Machine Market By Type , By Components By Application : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年體外膜氧合（ECMO）市值為5.042億美元，預計2024年至2033年複合年成長率為4.6%，到2033年達到7.937億美元。

體外膜氧合 (ECMO) 是醫療設備，有助於去除二氧化碳並將富氧血液送回體內。該機器充當生命維持機器，治療患有心肺功能障礙的患者。 ECMO 的工作原理是透過氧合器（膜氧合器）將血液循環回血流。這個過程為血液充氧並去除二氧化碳，有效地模仿了人類肺和心臟的功能。

體外膜氧合（ECMO）市場的全球成長主要是由心臟衰竭和心源性休克等呼吸系統和心臟疾病疾病盛行率的驚人上升所推動的。英國國家英國估計，約有 660 萬人患有心血管或呼吸系統疾病。其中，據報導有 350 萬人患有心血管疾病，370 萬人患有呼吸道疾病。此外，醫療保健專業人員意識的提高和醫療培訓的進步正在導致 ECMO 的廣泛使用。根據體外生命支持（ELSO）登記處 2023 年 6 月的評估，2020 年有 151,683 名患者使用了 ECMO。其中，成人 75,735 人，兒童 30,743 人，新生兒 45,205 人。此外，老年人口的快速增加也對市場成長做出了重大貢獻。這是因為老年人由於功能障礙而更容易患慢性病和器官衰竭，限制了他們進行日常活動的能力，從而推高了對 ECMO 的需求。根據世界衛生組織（WHO）的數據，2019年60歲以上的人口有10億人。預計到 2030 年，這一數字將增至 14 億，到 2050 年將增至 21 億，這可能會對市場成長做出重大貢獻。然而，ECMO系統的初始投資和維護成本，以及缺乏熟練的系統操作人員，正在阻礙市場的成長。此外，許多國家沒有足夠的醫療保健設施來滿足其人口的需求，而有限的醫療服務也是市場的主要阻礙因素。相反，ECMO 技術的不斷改進，包括更小、更有效率的系統，以及政府對重症患者醫療基礎設施安裝和開發的資金和支持的增加，預計將在預測期內擴大市場，從而提供利潤豐厚的機會。

體外膜氧合 (ECMO) 市場按類型、組件、應用和區域細分。依類型分類，市場分為靜脈-動脈、靜脈-靜脈和動-靜脈。按組件分類，它們分為泵浦、充氧器、控制器等。依用途分為成人、兒童、新生兒。按地區分類，對北美、歐洲、亞太地區和拉丁美洲地區市場進行了分析。

主要發現

按類型分類，預計到 2033 年動靜脈設備領域將主導市場。

從組成部分來看，制氧機預計將在預測期內成為主要細分市場。

從應用來看，成人市場預計在未來幾年將呈現顯著的複合年成長率。

按地區分類，北美是 2023 年的主要收益貢獻國家，並且很可能在預測期內主導市場。

可以自訂此報告（需要額外的費用和時間表）

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • SWOT分析

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章體外膜氧合（ECMO）市場：依類型

  • 市場概況
  • 靜脈動脈
  • 靜脈
  • 其他

第5章體外供氧（ECMO）市場：依組成部分

  • 市場概況
  • 泵浦
  • 氧氣供應
  • 控制器
  • 其他

第6章 體外供氧（ECMO）市場：依應用分類

  • 市場概況
  • 成人
  • 兒科的
  • 新生

第7章 體外膜氧合（ECMO）市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國體外膜氧合（ECMO）市場
    • 加拿大體外膜氧合（ECMO）市場
    • 墨西哥體外膜氧合（ECMO）市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國體外膜氧合（ECMO）市場
    • 德國體外膜氧合（ECMO）市場
    • 義大利體外膜氧合（ECMO）市場
    • 西班牙體外膜氧合（ECMO）市場
    • 英國體外膜氧合（ECMO）市場
    • 其他歐洲國家體外膜氧合 (ECMO) 市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國體外膜氧合（ECMO）市場
    • 日本體外膜氧合（ECMO）市場
    • 印度體外膜氧合（ECMO）市場
    • 韓國體外膜氧合（ECMO）市場
    • 澳洲體外膜氧合（ECMO）市場
    • 其他亞太地區體外膜氧合 (ECMO) 市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西體外膜氧合（ECMO）市場
    • 南非體外膜氧合（ECMO）市場
    • 沙烏地阿拉伯體外膜氧合（ECMO）市場
    • 其他拉丁美洲/中東/非洲體外膜氧合 (ECMO) 市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Medtronic Plc
  • Sorin Group
  • Terumo Corporation
  • MAQUET Holding
  • Nipro Medical Corporation
  • Microport Scientific Corporation
  • Medos Medizintechnik AG
  • GETINGE AB
  • Livanova Plc
  • Fresnius Medical Care
簡介目錄
Product Code: A284556

The extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.

Extracorporeal membrane oxygenation machine (ECMO) is a medical device that assists in removal of carbon dioxide and sends oxygen-rich blood back to the body. The machine serves as a life support system to treat individuals suffering from cardiac and pulmonary dysfunction. ECMO functions by circulating blood through an artificial lung (membrane oxygenator) and back into the bloodstream. This process allows the blood to be oxygenated and carbon dioxide to be removed, effectively mimicking the functions of human lungs and heart.

The growth of the global extracorporeal membrane oxygenation machine (ECMO) market is majorly driven by alarming rise in prevalence of respiratory and cardiac diseases such as heart failure and cardiogenic shock. According to the estimates of the Office of National Statistics, UK, approximately 6.6 million individuals were suffering from either a cardiovascular or respiratory condition. Among these, 3.5 million individuals were reported to have a cardiovascular condition, whereas 3.7 million had a respiratory condition. Moreover, increase in awareness among healthcare providers and advancements in medical training lead have led to a wider adoption of ECMO. Based on the June 2023 assessment by the Extracorporeal Life Support Organization (ELSO) registry, ECMO was used on 151,683 patients in 2020. Among these, 75,735 were adults, 30,743 were children, and 45,205 were neonates. Furthermore, surge in geriatric population notably contributes toward the market growth. . This is attributed to the fact that aged individuals are highly susceptible to chronic diseases and organ failure due to functional impairment that limit the ability to carry out day-to-day chores, thus boosting the demand for ECMO. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which is likely to significantly contribute toward the market growth. However, initial investment and maintenance costs of ECMO systems and dearth of skilled personnel to operate the system hamper the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in ECMO technology, including more compact and efficient systems, and increase in government funding and support to set up & develop critical care infrastructure are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The extracorporeal membrane oxygenation machine (ECMO) market is segmented into type, component, application, and region. Depending on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, it is classified into pumps, oxygenator, controllers, and others. On the basis of application, it is segregated into adult, pediatric, and neonates. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the arterio-venous machine segment is expected to dominate the market by 2033.

On the basis of component, oxygenator is anticipated to emerge as a leading segment during the forecast period.

Depending on application, the adult segment is projected to exhibit notable CAGR in the coming years.

Region wise, North America was the major revenue contributor in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global extracorporeal membrane oxygenation machine (ECMO) market include Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, GETINGE AB, Livanova Plc., and Fresnius Medical Care. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Veno-arterial
  • Veno-venous
  • Others

By Components

  • Pumps
  • Oxygenator
  • Controllers
  • Others

By Application

  • Adult
  • Pediatric
  • Neonates

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Medtronic Plc
    • Sorin Group
    • Terumo Corporation
    • MAQUET Holding
    • Nipro Medical Corporation
    • Microport Scientific Corporation
    • Medos Medizintechnik AG
    • GETINGE AB
    • Livanova Plc
    • Fresnius Medical Care

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Veno-arterial
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Veno-venous
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Components
  • 5.2. Pumps
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Oxygenator
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Controllers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Adult
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Pediatric
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Neonates
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Components
    • 7.2.4. Market Size and Forecast, By Application
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Components
      • 7.2.6.3. Market Size and Forecast, By Application
    • 7.2.7. Canada Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Components
      • 7.2.7.3. Market Size and Forecast, By Application
    • 7.2.8. Mexico Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Components
      • 7.2.8.3. Market Size and Forecast, By Application
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Components
    • 7.3.4. Market Size and Forecast, By Application
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Components
      • 7.3.6.3. Market Size and Forecast, By Application
    • 7.3.7. Germany Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Components
      • 7.3.7.3. Market Size and Forecast, By Application
    • 7.3.8. Italy Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Components
      • 7.3.8.3. Market Size and Forecast, By Application
    • 7.3.9. Spain Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Components
      • 7.3.9.3. Market Size and Forecast, By Application
    • 7.3.10. UK Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Components
      • 7.3.10.3. Market Size and Forecast, By Application
    • 7.3.11. Rest of Europe Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Components
      • 7.3.11.3. Market Size and Forecast, By Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Components
    • 7.4.4. Market Size and Forecast, By Application
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Components
      • 7.4.6.3. Market Size and Forecast, By Application
    • 7.4.7. Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Components
      • 7.4.7.3. Market Size and Forecast, By Application
    • 7.4.8. India Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Components
      • 7.4.8.3. Market Size and Forecast, By Application
    • 7.4.9. South Korea Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Components
      • 7.4.9.3. Market Size and Forecast, By Application
    • 7.4.10. Australia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Components
      • 7.4.10.3. Market Size and Forecast, By Application
    • 7.4.11. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Components
      • 7.4.11.3. Market Size and Forecast, By Application
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Components
    • 7.5.4. Market Size and Forecast, By Application
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Components
      • 7.5.6.3. Market Size and Forecast, By Application
    • 7.5.7. South Africa Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Components
      • 7.5.7.3. Market Size and Forecast, By Application
    • 7.5.8. Saudi Arabia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Components
      • 7.5.8.3. Market Size and Forecast, By Application
    • 7.5.9. Rest of LAMEA Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Components
      • 7.5.9.3. Market Size and Forecast, By Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic Plc
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Sorin Group
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Terumo Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. MAQUET Holding
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Nipro Medical Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Microport Scientific Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Medos Medizintechnik AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. GETINGE AB
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Livanova Plc
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Fresnius Medical Care
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments